Abivax Soars Over 500% on Game-Changing Ulcerative Colitis Drug News: What’s Driving the Surge?
Buckle up, folks, because the stock market is serving up some serious fireworks today, and Abivax (NASDAQ: ABVX) is lighting up the sky! As of this writing, ABVX is rocketing with a jaw-dropping gain of over 550%, making it one of the biggest movers in the market....